Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
Authors
Keywords
Idiopathic pulmonary fibrosis, Nanoparticles, Pathophysiology, Formulations, Inflammatory growth factors, Anti-fibrotic agents
Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 164, Issue -, Pages 1-12
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/j.ejpb.2021.03.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
- (2020) Marina R. Hadjicharalambous et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhalation of Tetrandrine- hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment
- (2020) Wenqiang Su et al. MOLECULAR PHARMACEUTICS
- Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
- (2020) Phuong-Uyen C. Dinh et al. Nature Communications
- Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
- (2020) Xin Chang et al. Science Advances
- Pharmacokinetic and pharmacodynamic evaluation of resveratrol loaded cationic liposomes for targeting hepatocellular carcinoma
- (2020) Satveer Jagwani et al. ACS Biomaterials-Science & Engineering
- Target-inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis
- (2020) Nikhil Hirani et al. EUROPEAN RESPIRATORY JOURNAL
- The therapeutic potential of galectin-3 inhibition in fibrotic disease
- (2020) R.J. Slack et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
- (2019) Jamie N. Justice et al. EBioMedicine
- The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom
- (2019) Vidya Navaratnam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice
- (2019) Elya A. Shamskhou et al. BIOMATERIALS
- Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
- (2019) Vahid Kheirollahi et al. Nature Communications
- The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis
- (2019) Hideki Amano et al. BIOMEDICINE & PHARMACOTHERAPY
- Benzoxaboroles—Novel Autotaxin Inhibitors
- (2019) Kraljić et al. MOLECULES
- Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
- (2019) Qiaoyu Liu et al. DRUG DISCOVERY TODAY
- Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes
- (2019) Yixin Wang et al. JOURNAL OF CONTROLLED RELEASE
- Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling
- (2019) Ka-Young Ryu et al. Journal of Neuroinflammation
- Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment
- (2019) Stefania Cerri et al. RESPIRATORY MEDICINE
- Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
- (2019) Caleb F. Anderson et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Thymoquinone-PLGA-PVA Nanoparticles Ameliorate Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulation of Inflammatory Cytokines and iNOS Signaling
- (2019) Sultan A. M. Saghir et al. Animals
- Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization
- (2019) Joshua Samuel et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
- (2019) Anna-Maria Hoffmann-Vold et al. EBioMedicine
- Phagocytosis of microparticles by alveolar macrophages during acute lung injury requires MerTK
- (2018) Michael P. Mohning et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis
- (2018) Marzieh Abnoos et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
- (2018) Dawei Ding et al. Materials Science & Engineering C-Materials for Biological Applications
- Metformin reverses established lung fibrosis in a bleomycin model
- (2018) Sunad Rangarajan et al. NATURE MEDICINE
- Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats
- (2018) Michel R. Corboz et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- WNT5a in Extracellular Vesicles – A New Frontier for Pulmonary Fibrosis
- (2018) Farida Ahangari et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Increased Extracellular Vesicles Mediate WNT-5A Signaling in Idiopathic Pulmonary Fibrosis
- (2018) Aina Martin-Medina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
- (2018) Tejal Rawal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles
- (2018) Yuzhen Hu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Developmental pathways in the pathogenesis of lung fibrosis
- (2018) Diptiman Chanda et al. MOLECULAR ASPECTS OF MEDICINE
- Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
- (2018) Martin Kolb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis
- (2018) Ioanna Ninou et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
- (2018) Akira Saito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice
- (2018) Laura A. Hancock et al. Nature Communications
- Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
- (2018) E. Bargagli et al. Pulmonology
- Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis
- (2017) Rokhsana Rasooli et al. INFLAMMATION
- Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis
- (2017) Jing Tang et al. International Journal of Nanomedicine
- MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
- (2017) Chaoqun Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis
- (2017) Pengxiu Cao et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis
- (2017) Nicolas Desroy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
- (2017) Juan Shi et al. MEDIATORS OF INFLAMMATION
- Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)
- (2017) Olga. B. Garbuzenko et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
- (2017) Jonathan A. Galli et al. RESPIROLOGY
- Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
- (2017) Richard J Allen et al. Lancet Respiratory Medicine
- Role of pirfenidone in the management of pulmonary fibrosis
- (2017) Keith Meyer et al. Therapeutics and Clinical Risk Management
- Novel Mechanisms for the Antifibrotic Action of Nintedanib
- (2016) Sunad Rangarajan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles
- (2016) Changkyu Lee et al. BIOMEDICINE & PHARMACOTHERAPY
- Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations
- (2016) Helen E. Jo et al. DRUGS & AGING
- Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review
- (2016) Zahra Gholamnezhad et al. JOURNAL OF ETHNOPHARMACOLOGY
- Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury
- (2016) Priya Ravikumar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model
- (2016) Jisoo Seo et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
- (2016) Ji Yhee et al. Journal of Clinical Medicine
- Reemergence of Hedgehog Mediates Epithelial–Mesenchymal Crosstalk in Pulmonary Fibrosis
- (2015) Biao Hu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways
- (2015) Xingqi Deng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?
- (2015) Mareike Klinger-Strobel et al. Expert Opinion on Drug Delivery
- Different profiles of notch signaling in cigarette smoke-induced pulmonary emphysema and bleomycin-induced pulmonary fibrosis
- (2015) Shi Li et al. INFLAMMATION RESEARCH
- Nanotechnology approaches for inhalation treatment of lung diseases
- (2015) Andriy Kuzmov et al. JOURNAL OF CONTROLLED RELEASE
- Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis
- (2015) YING-YING HAN et al. Molecular Medicine Reports
- Hyaluronidase-Loaded PLGA Microparticles as a New Strategy for the Treatment of Pulmonary Fibrosis
- (2015) Claudia da Silva Bitencourt et al. TISSUE ENGINEERING PART A
- Inhaled tacrolimus modulates pulmonary fibrosis without promoting inflammation in bleomycin-injured mice
- (2015) P. Shivshankar et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Polymeric nanoparticles for pulmonary protein and DNA delivery
- (2014) Jyothi U. Menon et al. Acta Biomaterialia
- Montelukast-loaded nanostructured lipid carriers: Part II Pulmonary drug delivery and in vitro–in vivo aerosol performance
- (2014) Arpana Patil-Gadhe et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Medical nanoparticles for next generation drug delivery to the lungs
- (2014) S. H. van Rijt et al. EUROPEAN RESPIRATORY JOURNAL
- Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery
- (2014) Chetna Dhand et al. RSC Advances
- Nanotechnology approaches for inhalation treatment of fibrosis
- (2013) Ronak Savla et al. JOURNAL OF DRUG TARGETING
- Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice
- (2012) Ruchit Trivedi et al. NANOTECHNOLOGY
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Influence of particle size on regional lung deposition – What evidence is there?
- (2011) Thiago C. Carvalho et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Controlled pulmonary drug and gene delivery using polymeric nano-carriers
- (2011) Moritz Beck-Broichsitter et al. JOURNAL OF CONTROLLED RELEASE
- A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis
- (2011) Max A. Seibold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Targeting of Nanoparticle Drug Matrices
- (2010) Preshit Dandekar et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
- (2010) Flavia V Castelino et al. ARTHRITIS RESEARCH & THERAPY
- Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners
- (2009) Kathleen Oare Lindell et al. HEART & LUNG
- N-acetyl-l-cysteine inhibits TGF-β1-induced profibrotic responses in fibroblasts
- (2009) Hisatoshi Sugiura et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started